Name: Dr. Laurent Meijer

Position: Chairman & Chief Scientific Officer

Research Description:

Dr. Laurent Meijer is the co-founder of ManRos Therapeutics & Perha Pharmaceuticals, and one of the world’s leading experts in disease-relevant kinases and their pharmacological inhibitors. Dr. Meijer has generated more than 40 patents, published over 320 articles, edited 6 books and has been working with three Nobel Prize recipients. In 1985-86, with Edwin Krebs (Nobel Prize award 1992), he extensively characterized the M-phase specific Histone H1 kinase (which turned out to be CDK1/cyclin B). In the late ’80s, with Tim Hunt (Nobel Prize award 2001), he identified the CDK1 associated regulatory subunit as cyclin B. With Paul Greengard (Nobel Prize award 2000), he has been studying brain protein kinases and pharmacological inhibitors for three years (2001-2004) at the Rockefeller University (New York).
Laurent Meijer holds a PhD from University of Lille (1978) and University of Paris (1983). He is married and has two children.

Contact Information

Web Page: https://www.linkedin.com/in/laurent-meijer-53174110/